Mymetics Corporation

Mymetics Corporation

MYMX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$91.13K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mymetics CorporationMymetics Corporation0-15%--1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$91,127.00
Enterprise Value$75.14 Million
Earnings per Share$-0.02
Beta2.41
Outstanding Shares303,758,000

Return

Return on Equity15.31%ROE
Return on Assets-11567.00%
Return on Invested Capital11.97%

Valuation & Multiples

P/E Ratio-0.02P/E Ratio
PEG0.03PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue208.92
Enterprise Value to EBIT-8.32
Enterprise Value to Net Income-7
Total Debt to Enterprise1
Debt to Equity-0.99Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Mymetics Corporation

2 employees
CEO: Ronald Kempers

Mymetics Corporation is a Swiss biotechnology company dedicated to the research and development of vaccines aimed at preventing infectious and debilitating diseases. Its robust pipeline features several promising vaccine candidates, incl...